Objective: The aim: Predicting the effectiveness of treatment for MRI of the lungs by developing a mathematical model to predict treatment outcomes.
Patients And Methods: Materials and methods: 84 patients with MRI of the lungs: group 1 (n = 56) - with signs of effective TB treatment at the end of the intensive phase; group 2 (n = 28) - patients with signs of ineffective treatment. We used the multivariate discriminant analysis method using the statistical environment STATISTICA 13.
Results: Results: During the discriminant analysis, the parameters of the clinical blood analysis (monocytes, stab leukocytes, erythrocytes) were selected, which were associated with high (r> 0.5) statistically significant correlations with the levels of MMP-9, TIMP-1, oxyproline and its fractions and aldosterone in the formation of the prognosis. The mathematical model allows, in the form of comparing the results of solving two linear equations and comparing their results, to predict the outcome of treatment: "1" effective treatment, "2" - ineffective treatment. Early prediction of treatment effectiveness is promising, as it allows the use of the developed mathematical model as an additional criterion for the selection of patients for whom surgical treatment is recommended, in order to increase the effectiveness of treatment.
Conclusion: Conclusions: An additional criterion for predicting ineffective MRI treatment, along with the criteria provided for by WHO recommendations, is a mathematical model that takes into account probably strong correlation (r = 0.5, p <0.05) between the factors of connective tissue destruction, collagen destruction, aldosterone , and indicators of a clinical blood test (between levels of OBZ and monocytes (r = 0.82, p = 0.00001), OB and monocytes (r = 0.92, p = 0.000001) OB and stab leukocytes (r = - 0.87, p = 0.0003) OBZ and stab leukocytes (r = - 0.53, p = 0.017), aldosterone and ESR.
Download full-text PDF |
Source |
---|
Introduction: This scoping review examines the application and evolution of the Social-Ecological Model for Adolescent and Young Adult Readiness for Transition (SMART). SMART provides a framework for assessing transition readiness across pediatric chronic conditions. Evaluating its research and clinical applications identifies insights and gaps across conditions and stakeholders.
View Article and Find Full Text PDFPostepy Biochem
December 2024
Katedra Biotechnologii, Wydział Nauk Biologicznych, Uniwersytet Zielonogórski.
Koronawirusy wywołują choroby dróg oddechowych, przewodu pokarmowego i centralnego układu nerwowego, które zagrażają zdrowiu ludzkiemu i przyczyniają się do strat ekonomicznych. Nowatorskie technologie wytwarzania powodują możliwość wykorzystania związków bioaktywnych jako czynników przeciwwirusowych. Większość owoców, warzyw oraz produktów pochodzenia roślinnego zawiera w składzie flawonoidy.
View Article and Find Full Text PDFPostepy Biochem
December 2024
Cellular Neurobiology Research Group, Faculty of Biology, University of Warsaw.
Udar mózgu jest wyniszczającą chorobą o podłożu sercowo-naczyniowym o wysokiej śmiertelności, prowadzącą do znacznego obniżenia jakości oraz długości życia. Z uwagi na złożoność patofizjologicznych procesów zachodzących po udarze mózgu u ludzi, kluczowe znaczenie z punktu widzenia rozwoju metod leczenia pacjentów mają badania podstawowe z użyciem zwierzęcych modeli udaru mózgu, ze szczególnym uwzględnieniem modeli z zastosowaniem gryzoni. Modele takie jak przejściowa lub trwała okluzja tętnicy środkowej mózgu (MCAo) i modele fotouczuleniowe są najczęściej stosowane w symulacji udaru niedokrwiennego i zostały szczegółowo opisane w niniejszej pracy.
View Article and Find Full Text PDFViruses
December 2024
College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong 030801, China.
Coinfections with porcine circovirus types 2, 3, and 4 (PCV2, PCV3, and PCV4) are increasingly being detected in the swine industry. However, there is no commercially available vaccine which prevents coinfection with PCV2, PCV3, and PCV4. The development of a vaccine expressing capsid (Cap) fusion proteins of multiple PCVs represents a promising approach for broadly preventing infection with PCVs.
View Article and Find Full Text PDFViruses
December 2024
Gilead Sciences, Inc., Foster City, CA 94404, USA.
Ebola virus (EBOV) causes severe disease in humans, with mortality as high as 90%. The small-molecule antiviral drug remdesivir (RDV) has demonstrated a survival benefit in EBOV-exposed rhesus macaques. Here, we characterize the efficacy of multiple intravenous RDV dosing regimens on survival of rhesus macaques 42 days after intramuscular EBOV exposure.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!